Using non-hypothesized based approaches for biomarker development
Using non-hypothesized based approaches for biomarker development
Jessica Gill, PhD, RN, FAAN, Bloomberg Distinguished Professor at Johns Hopkins School of Nursing, presents research on a highly multiplexed proteomic technique that used a DNA aptamers assay to target 1,305 proteins in plasma samples from athletes with and without a sports-related concussion (SRC). Researchers identified 338 plasma proteins significantly differed in abundance in concussed athletes compared to non-concussed athletes.
Learning objectives
- Understand current limits of protein quantification
- Describe ways to improve biomarker identification and measurement related to brain injuries
- Determine ways to address current limitations to personalized medicine approaches for brain injuries
Jessica Gill, PhD, RN, FAAN
Bloomberg Distinguished Professor
Johns Hopkins School of Nursing
Jessica Gill is a national leader in research on the biological mechanisms of traumatic brain injuries (TBI). She has spent decades investigating differential responses in military personnel, athletes, and other patients that have experienced TBIs and the mechanisms underlying these divergent responses. Specifically, Dr. Gill looks for ways to use biomarkers to identify which patients are at high risk for poor recovery and long-term effects including post-traumatic stress disorder, depression, and post-concussive syndrome, and to develop treatments.
After earning her PhD at JHSON, she went to the National Institutes of Health (NIH) to complete a postdoctoral fellowship at the National Institute of Nursing Research that focused on the biological mechanisms of PTSD and depression. At NIH, she also served as a senior investigator and acting deputy scientific director of the National Institute of Nursing Research and deputy director of the Center for Neuroscience and Regenerative Medicine. Dr. Gill was the first nurse to receive the Lasker Clinical Research Scholar Award, considered the most prestigious research grant given by the NIH. As Bloomberg Distinguished Professor of Trauma Recovery Biomarkers, she will hold primary appointments in the Johns Hopkins School of Nursing and the School of Medicine, Department of Neurology.
Using non-hypothesized based approaches for biomarker development
A presentation by Jessica Gill, PhD, RN, FAAN
More webinars
WebinarEvaluation of precision and correlation for the latest proteomic platforms
The field of proteomics is rapidly advancing, enabling precise measurement of thousands of proteins, particularly those in higher abundance. This webcast will explore significant differences in precision within and across the latest large-scale proteomic platforms and their intercorrelations, based on blind duplicate split assays of the leading modified aptamer-based 11K and antibody proximity ligation-based 5K platforms. Each platform exhibits distinct strengths and limitations, requiring careful consideration prior to implementation in individual studies.
WebinarScaling Proteomics: Balancing Performance and Measuring Enough Proteins
As proteomics platforms have advanced, the number of proteins measured and sample throughput have dramatically increased. However, have sacrifices or trade-offs been necessary to make these gains? To find out, Stephen Williams will analyze how the performance of proteomics platforms has changed over time, comparing precision, sensitivity and specificity as throughput increases.
WebinarFrom discovery to clinical insights – the power of integrating proteomics and genomics data
The value of adding high-plex proteomics to existing genomics data and how proteogenomic approaches accelerate drug target discovery and repurposing. Watch this presentation given by Maik Pietzner, PhD, at ESHG 2024.